OOIR: Observatory of International Research

Papers

(The median citation count of Current Opinion in Endocrinology Diabetes and Obesity is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Utilizing type 2 diabetes medications outside glycemic parameters – where are we headed?	55
Obesity and infertility: a double whammy	41
Updates in thyroid healthcare delivery: advancing patient-centered care	40
Editorial: Health considerations across the lifespan for patients with polycystic ovary syndrome	35
Advances in assessment and treatment of bone, mineral and parathyroid disorders	34
MR-based techniques for intracortical vessel visualization and characterization: understanding the impact of microvascular disease on skeletal health	30
Nutrition and thyroid disease	28
Editorial introduction	25
Editorial introduction	25
Detection strategies for elevated lipoprotein(a): will implementation let the genie out of the bottle?	22
Beyond weight loss: tirzepatide as a dual GIP/GLP-1 receptor agonist for obstructive sleep apnea	22
Prevalence and correlates of androgen dependence: a meta-analysis, meta-regression analysis and qualitative synthesis	22
Recent advances in anaplastic thyroid cancer management	20
Secondary hyperparathyroidism in chronic kidney disease: update on pathophysiology and new treatment targets	19
Financial toxicity in thyroid cancer survivors	16
Interactions between antidiabetes medications and heart–brain axis	15
Editorial introduction	15
The use of anabolic agents in the treatment of osteoporosis: a clinical update	15
Update on fracture risk assessment in osteoporosis	15
An update on bone in diabetes	15
Bone marrow fibrocytes: villain or white knight in thyroid-associated ophthalmopathy?	14
Fibrous dysplasia in children and its management	14
Targeting apolipoprotein C-III: a game changer for pancreatitis prevention in severe hypertriglyceridemia	13
Low-carbohydrate diets in type 1 diabetes: balancing benefits and risks	13
A short history of saturated fat: the making and unmaking of a scientific consensus	12

Precision medicine in diabetes care	12
Editorial introductions	12
Epidemiologic changes in thyroid disease	12
Editorial introductions	12
New perspectives on the high-density lipoprotein system and its role in the prevention and treatment of atherosclerotic cardiovascular disease	11
Recent advances in fibroblast growth factor 23-related hypophosphatemic disorders	11
Hypertriglyceridemia: updates from clinical trials of new agents and real-world registries	11
TSHR-IGF-IR complex drives orbital fibroblast misbehavior in thyroid eye disease	11
Editorial introductions	10
Assisted reproductive technology outcomes and management considerations for people with epilepsy	10
Type 2 diabetes: a contemporary view from the Asian lens	10
Glucocorticoid withdrawal syndrome: what to expect and how to manage	10
An update on investigation and management of renal bone disease	10
Editorial introductions	9
Legislation, medicine, and politics: care for gender diverse youth	9
Short-term hyper-caloric high-fat feeding on a ketogenic diet can lower low-density lipoprotein cholesterol: the cholesterol drop experiment	9
Novel techniques for assessment of bone tissue material properties	9
Indications for testosterone therapy in men	8
Editorial introductions	8
Multifactorial chylomicronemia syndrome	7
The interaction between gut microbiome and bone health	7
Treating obesity in type 1 diabetes mellitus – review of efficacy and safety	7
The future of triglyceride-regulating therapies and registries	7
Microbiome-derived signaling molecules and the brain–gut axis: emerging mechanisms and clinical implications	7
Time to cycle regularity and health risks	7
Revisiting the relationship between weight loss and bone health in people living with obesity: insights from the latest evidence	7
Assessing the contribution of plastic-associated obesogenic compounds to cardiometabolic diseases	6
Gestational diabetes and other adverse pregnancy outcomes in polycystic ovary syndrome	6
The 1 mg overnight dexamethasone suppression test: a danger to the adrenal gland?	6
The psychosocial impact of thyroid cancer	6
Type 2 diabetes mellitus and cognitive function: understanding the connections	6
Predictors of cardiovascular risk in familial hypercholesterolemia	5
Testosterone and the prevention of type 2 diabetes mellitus: therapeutic implications from recent trials	5
Editorial introductions	5
When history, law, and medicine intersect	5
Radiofrequency ablation (RFA) compared to observation for benign thyroid nodules: emerging considerations for judicious use	5
Hypoparathyroidism update	4
Editorial: Childhood endocrine and genetic disorders: improving adult outcomes	4
Coronary artery event-free or resilient familial hypercholesterolemia: what's in a name?	4
Can artificial intelligence and wearable technologies transform diabetes foot health?	4
Skeletal health in diabetes	4
Prediabetes and skeletal health	4
The psychological dimension of obesity – an uncharted territory	4
Cardiometabolic risk and therapeutic outcomes in mild autonomous cortisol secretion	4
Update on management of paediatric dyslipidaemia	4
Potassium-competitive acid blockers and acid-related disorders	4
Current challenges in Cushing's syndrome testing: blood, saliva, urine, or hair?	4
Recent advances in the role of miRNAs in bone disease	4
Mixed-methods research on androgen abuse – a review	4
Overview of diabetes agents in cardiovascular disease: it takes an orchestra to play Tchaikovsky in symphony	4

Editorial introductions	4
Cardiovascular disease in metabolic-associated fatty liver disease	4
Editorial: New horizons for thyroid diseases: transformative changes and tailored care	4
Preconception health optimization in women with polycystic ovary syndrome − how to find the time?	4
Metabolic dysfunction and the use of adjunct medications in type 1 diabetes	4
The approaches and challenges in the management of differentiated thyroid carcinoma	3
Health effects of androgen abuse: a review of the HAARLEM study	3
Subclinical hyperthyroidism	3
Use of anti-Müllerian hormone for understanding ovulatory dysfunction in polycystic ovarian syndrome	3
Parathyroid hormone assays in 2026: second versus third generation, standardization, and clinical interpretation	3
Obesity during pregnancy: contemporary evidence and clinical implications	3
Biomarkers in gastroenteropancreatic neuroendocrine neoplasms	3
Adjunctive diabetes therapies and cardiovascular protection in type 1 diabetes: tackling the challenging Tchaikovsky piece	3
An update: maternal iodine supplementation, thyroid function tests, and child neurodevelopmental outcomes	3
Better care for women with polycystic ovary syndrome – a proposal for an international evidence based best practice framework to improve care	3
Glucagon-like peptide-1 receptor agonists and safety in the preconception period	2
The evolution of C-peptide's role in diabetes care	2
Adherence to pharmacotherapy: sine qua non for reducing cumulative risk of premature coronary disease in familial hypercholesterolemia	2
Editorial introduction	2
Molecular testing for indeterminate thyroid nodules: past, present, and future	2
Editorial introductions	2
GLP-1RA based therapies in the young and old	2
Editorial introductions	2
Editorial introduction	2
Use of calculated free testosterone in men: advantages and limitations	2
Editorial introductions	2
Effect of incretins on skeletal health	2
Molecular tools for diagnosing diseases of the adrenal cortex	2
Eicosapentaenoic acid vs. docosahexaenoic acid for the prevention of cardiovascular disease	2
Editorial introduction	2
Editorial overview	2
Emerging concepts in the diagnosis and management of metabolically associated steatotic liver disease	2
Obesity-related glomerulopathy: a lesser known complication of obesity	2
Current perspectives on biomarkers in metabolic bone disease	2
Addressing genetic and environmental sources of cardiometabolic disease	2
An overview of persistent chylomicronemia: much more than meets the eye	2
Effect of GLP-1 receptor agonists on body composition	2
Editorial introductions	2
Can remnant cholesterol (triglyceride-rich lipoproteins) reclassify estimated risk of atherosclerotic cardiovascular disease?	2